









Markets
/
Stocks
/
nasdaq-coo
/

Cooper Companies Inc

COO

71.540USD

+0.090+0.13%

Close 03/26, 16:00（ET）Quotes delayed by 15 min

13.55BMarket Cap

35.26P/E TTM



Cooper Companies Inc

71.540

+0.090+0.13%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Cooper Companies Inc

Currency: USD Updated: 2026-03-25

Key Insights

Cooper Companies Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 41 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 91.73.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cooper Companies Inc's Score

Industry at a Glance

Industry Ranking

41 / 209

Overall Ranking

127 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Cooper Companies Inc Highlights

StrengthsRisks

The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 4.09B.

Undervalued

The company’s latest PE is 35.22, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 208.96M shares, decreasing 0.00% quarter-over-quarter.

Held by Ron Baron

Star Investor Ron Baron holds 664.49K shares of this stock.

Analyst Rating

Based on 21 analysts

Buy

Current Rating

91.732

Target Price

+30.60%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-25

The current financial score of Cooper Companies Inc is 6.89, ranking 105 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 1.02B, representing a year-over-year increase of 6.16%, while its net profit experienced a year-over-year increase of 25.41%.

Score

Industry at a Glance

Previous score

6.89

Change



Financials

5.13

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.36

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.74

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.43

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.81

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Cooper Companies Inc's Company Valuation

Currency: USD Updated: 2026-03-25

The current valuation score of Cooper Companies Inc is 6.98, ranking 134 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 35.22, which is 151.54% below the recent high of 88.59 and 15.14% above the recent low of 29.89.

Score

Industry at a Glance

Previous score

6.98

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 41/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-25

The current earnings forecast score of Cooper Companies Inc is 7.43, ranking 132 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 93.00, with a high of 100.00 and a low of 71.00.

Score

Industry at a Glance

Previous score

7.43

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 21 analysts

Buy

Current Rating

91.732

Target Price

+30.13%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Cooper Companies Inc

COO

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-25

The current price momentum score of Cooper Companies Inc is 6.81, ranking 90 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 80.72 and the support level at 65.67, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.72

Change

0.09

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.149

Sell

RSI(14)

34.162

Neutral

STOCH(KDJ)(9,3,3)

50.961

Buy

ATR(14)

2.059

Low Volatility

CCI(14)

-1.471

Neutral

Williams %R

66.191

Sell

TRIX(12,20)

-0.654

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

70.736

Buy

MA10

70.857

Buy

MA20

74.688

Sell

MA50

79.043

Sell

MA100

78.417

Sell

MA200

74.619

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-25

The current institutional shareholding score of Cooper Companies Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 111.56%, representing a quarter-over-quarter decrease of 0.16%. The largest institutional shareholder is The Vanguard, holding a total of 23.46M shares, representing 12.02% of shares outstanding, with 1.01% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

23.88M

-1.17%

BlackRock Institutional Trust Company, N.A.

9.84M

+0.81%

Capital World Investors

10.55M

+25.73%

T. Rowe Price Investment Management, Inc.

9.83M

+33.16%

State Street Investment Management (US)

8.59M

-0.85%

Kayne Anderson Rudnick Investment Management, LLC

7.55M

-3.88%

T. Rowe Price Associates, Inc.

Star Investors

3.50M

-44.00%

Geode Capital Management, L.L.C.

5.30M

+1.87%

Wellington Management Company, LLP

6.18M

+332.88%

Risk Assessment

Currency: USD Updated: 2026-03-25

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Cooper Companies Inc is 8.35, ranking 23 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.08. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Cooper Companies Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.